These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins. Ippagunta SK; Pollock JA; Sharma N; Lin W; Chen T; Tawaratsumida K; High AA; Min J; Chen Y; Guy RK; Redecke V; Katzenellenbogen JA; Häcker H Sci Signal; 2018 Aug; 11(543):. PubMed ID: 30108181 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway. Lin YC; Huang DY; Chu CL; Lin WW Mol Immunol; 2010 Apr; 47(7-8):1569-78. PubMed ID: 20138367 [TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy. Li TT; Ogino S; Qian ZR World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469 [TBL] [Abstract][Full Text] [Related]
5. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands. Arsenault RJ; Kogut MH; He H Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795 [TBL] [Abstract][Full Text] [Related]
6. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Lee JK; Kim SY; Kim YS; Lee WH; Hwang DH; Lee JY Biochem Pharmacol; 2009 Apr; 77(8):1391-400. PubMed ID: 19426678 [TBL] [Abstract][Full Text] [Related]
7. Targeting toll-like receptor signaling pathways for design of novel immune therapeutics. Hong-Geller E; Chaudhary A; Lauer S Curr Drug Discov Technol; 2008 Mar; 5(1):29-38. PubMed ID: 18537565 [TBL] [Abstract][Full Text] [Related]
8. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells. Tartey S; Takeuchi O Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562 [TBL] [Abstract][Full Text] [Related]
10. Small-Molecule Modulators of Toll-like Receptors. Wang Y; Zhang S; Li H; Wang H; Zhang T; Hutchinson MR; Yin H; Wang X Acc Chem Res; 2020 May; 53(5):1046-1055. PubMed ID: 32233400 [TBL] [Abstract][Full Text] [Related]
11. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Martin MU; Wesche H Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671 [TBL] [Abstract][Full Text] [Related]